Accuray
- Company typePublic
- Founded1990
- HeadquartersSunnyvale, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Accuray firmographics
Firmographics- Name
- Accuray
- Legal name
- Accuray Incorporated
- Website
- https://accuray.com
- Company type
- Public
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Accuray industry classification
Industry- Product category
- Radiation Therapy Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
Keywords
Where Accuray is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Accuray business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Radiotherapy System Hardware Sales: Sale of radiation therapy delivery systems including CyberKnife, Radixact, and TomoTherapy platforms. Revenue recognized upon system installation and acceptance. Q3 FY2026 product revenue was $49.7 million.
- Service and Maintenance Contracts: Ongoing service contracts and maintenance support for installed radiotherapy systems. Service revenue declined 1% year-over-year in Q3 FY2026, indicating recurring revenue from existing customer base.
- Software Licenses and Upgrades: Treatment planning software (Accuray Precision), data management systems (iDMS), and upgrade packages including VOLO Ultra, CyberComm, and ClearRT imaging enhancements available through service agreements or separate purchases.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on system configuration |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Accuray product offering
Product offeringCore offering
Accuray designs, manufactures, and sells advanced radiation therapy delivery systems and supporting software for cancer treatment. Its portfolio centers on the CyberKnife robotic radiosurgery platform and the Radixact helical radiation therapy system, supplemented by treatment planning software (Accuray Precision), data management (iDMS), and adaptive therapy tools. The company also generates recurring revenue through service contracts and software upgrades sold to installed-base customers.
Product overview
Accuray is a radiation therapy solutions company offering a comprehensive portfolio of radiotherapy delivery systems and software. The product lineup centers on the CyberKnife robotic radiosurgery platform (S7, M6) and the Radixact helical tomotherapy system, both supported by the Accuray Precision Treatment Planning software and iDMS Data Management platform. Key differentiating technologies include Synchrony real-time motion synchronization for adaptive treatment delivery, ClearRT high-fidelity imaging, VOLO Ultra optimizer, and VitalHold surface-guided radiotherapy. The portfolio extends to the legacy TomoTherapy system, adaptive radiotherapy software suite, and veterinary oncology applications. All treatment systems connect through the unified Accuray Precision/iDMS ecosystem with interoperability to major oncology information systems including ARIA, MOSAIQ, and RayCare.
Differentiator
Problem solved
Functional benefit
Brands
- CyberKnife: Robotic radiosurgery system for precise radiation treatment delivering SRS and SBRT anywhere in the body with sub-millimeter accuracy
- Radixact
- TomoTherapy
- Accuray Precision
- iDMS
- Synchrony
- ClearRT
- VOLO
- VitalHold
- Stellar
- Helix
- Accuray Exchange (AEx)
Products and services
- CyberKnife S7 System Robotic radiosurgery system that delivers stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) anywhere in the body with sub-millimeter precision and integrated AI-driven Synchrony real-time motion synchronization. Sold to hospitals and cancer treatment centers.
- CyberKnife M6 System Robotic radiosurgery system delivering stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) with true robotic precision and integrated AI-driven Synchrony real-time target tracking, for hospitals and cancer centers.
- Radixact System Helical radiation therapy system with integrated 3D kVCT and MVCT imaging for advanced image-guided intensity-modulated radiation therapy (IG-IMRT) and 3D conformal radiation therapy (3DCRT), featuring an ultra-fast multi-leaf collimator. Sold to hospitals and cancer treatment centers.
- TomoTherapy System Helical radiation therapy system providing image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) with integrated 3D image guidance and highly conformal treatments enabled by a binary MLC, for hospitals and cancer centers.
- Accuray Precision Treatment Planning Centralized treatment planning software for all Accuray systems, providing features including VOLO optimizer, PreciseART adaptive therapy, PreciseRTX re-treatment option, AutoSegmentation auto-contouring, and multimodality image fusion with deformable registration. Used by radiation oncologists and medical physicists.
- iDMS Data Management System Integrated data management system that connects all Accuray treatment planning and delivery systems, providing centralized storage and management of patient and system data with connectivity to major Oncology Information Systems including ARIA, MOSAIQ, and RayCare. Sold to hospitals and cancer centers.
- Veterinary Oncology Solutions Radiation therapy solutions for veterinary oncology applications, enabling pet and animal cancer treatment using CyberKnife and Radixact systems. Targeted at veterinary hospitals and specialty clinics offering cancer treatment for animals.
- VitalHold Surface-Guided Radiotherapy Surface-guided radiotherapy (SGRT) solution providing patient setup and monitoring, including deep inspiration breath hold (DIBH) treatments with TomoDirect treatment delivery on Radixact systems. 510(k) cleared and EU market cleared. Sold to hospitals and cancer centers.
- Adaptive Suite Comprehensive suite of tools for adaptive radiotherapy workflows on Accuray systems, enabling personalized cancer treatments through real-time adaptive planning and delivery adjustments. Sold to hospitals and cancer centers.
Quantifiable outcome
- Treatment delivery times as short as 15 minutes with VOLO optimization and ultra hypofractionated protocols
- +2 more outcomes
Companies that use Accuray
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Accuray technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability7 records
Feature8 records
Accuray partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and flagship.
- University of Wisconsin School of Medicine and Public Healthcore10-year Master Research Agreement announced May 2026 to advance personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform. The collaboration supports clinical research, education, training, and development of adaptive therapies. Built on partnership dating back to late 1980s when UW Professor Thomas Mackie invented technology that became Accuray's TomoTherapy System. Aims to translate research innovations into patient care technologies.
- BrainlabcorePartnership enables neuro-radiosurgery community to leverage Accuray treatment delivery with Brainlab Elements planning software optimized for neurosurgeons. Enhances interoperability with Snke OS platform and enables CyberKnife treatment data integration via Quentry patient registry platform for neuro-radiosurgery patient registries.
- GE HealthCareflagshipGlobal commercial collaboration bringing together GE Healthcare's precision diagnostic tools and Accuray's radiation therapy delivery capabilities. Provides comprehensive offering for tailoring patient care at every treatment stage and improving cancer outcomes. Combines diagnostic and treatment technologies for personalized cancer care.
- RaySearchcoreLong-term collaboration to develop and market integrated solutions combining RayStation treatment planning system with CyberKnife and Radixact platforms plus RayCare oncology information system. Enables clinical teams to leverage RaySearch software with Accuray technologies, providing flexibility for hospitals with multiple treatment systems.
- Limbus AIcorePartnership for development of Accuray's next-generation adaptive treatment application. Limbus AI specializes in AI-driven automatic contouring algorithms focused on contour accuracy for efficient treatment planning and adaptive therapy. Headquartered in Regina, Saskatchewan, Canada.
- AlphaXRTcoreAccuray distributor in Australia providing ongoing support, on-site engineering, and predictive maintenance for Accuray systems. Supported installation and training for 5D Clinics Melbourne CyberKnife System, including rapid response to technical issues and proactive maintenance support.
- Icon GroupcoreJoint venture partner with 5D Clinics for CyberKnife System installation in Melbourne, Australia. Icon Group provides oncology services expertise and support for market expansion in Australian healthcare market through combined expertise.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Accuray competitors and assessment
Company assessmentDirect peers
- Varian Medical Systems (Siemens Healthineers): Varian is the global market leader in linear accelerator (LINAC) radiation therapy systems, holding a dominant installed base. It is the most direct competitor to Accuray's Radixact and TomoTherapy platforms in image-guided and intensity-modulated radiation therapy, and was acquired by Siemens Healthineers in 2021.
- Elekta: Swedish-headquartered Elekta is the other global LINAC incumbent alongside Varian, offering competing image-guided radiation therapy and stereotactic radiosurgery systems. It directly competes with Accuray in hospitals and cancer centers worldwide, particularly in Europe and emerging markets.
- RaySearch Laboratories: RaySearch develops RayStation treatment planning and RayCare oncology information systems that integrate with multiple LINAC platforms including Accuray's CyberKnife and Radixact. It is both a partner (via iDMS integration) and a software competitor in the treatment planning ecosystem.
Emerging players
- Brainlab: Brainlab specializes in radiosurgery treatment planning software and neurosurgical navigation. While also an Accuray integration partner, it overlaps competitively in neuro-radiosurgery planning workflows where CyberKnife is also sold.
- ViewRay: ViewRay's MRIdian system combines MRI imaging with radiation therapy delivery, competing in the image-guided radiation therapy space with a differentiated real-time soft-tissue visualization approach. Targets similar adaptive radiotherapy use cases as Accuray's Stellar and Radixact platforms.
- Mevion Medical Systems: Mevion is a U.S.-based developer of compact proton therapy systems. While proton therapy is a different modality, it competes for the same hospital capital equipment budgets and advanced radiotherapy service-line expansion as Accuray's CyberKnife and Radixact.
- IntraOp Medical: IntraOp Medical manufactures the Mobetron, a mobile electron beam intraoperative radiation therapy system. It addresses a more specialized radiation oncology niche but competes with Accuray for advanced radiotherapy capital purchasing at comprehensive cancer centers.
- Sensus Healthcare: Sensus Healthcare develops superficial radiation therapy (SRT) systems primarily for skin cancer and keloid treatment. While not a direct LINAC competitor, it competes for radiation oncology capital dollars in dermatology and superficial treatment settings adjacent to Accuray's market.
Broad incumbents
- Hitachi (particle therapy systems): Hitachi's healthcare division offers proton and heavy ion therapy systems. While not a direct LINAC competitor, it competes with Accuray for advanced radiotherapy capital budget allocations at large academic medical centers.
Others
- C-RAD: C-RAD provides patient positioning, surface imaging, and motion management solutions for radiation therapy. It is both a technology partner with Accuray and an enabler of advanced radiotherapy workflows that complement Accuray's systems.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Accuray social profiles
Digital presenceAccuray compliance and trust
Trust signalCompliance1 record
Accuray financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accuray leadership team
Management profileNumber of profiles
Profiles4 records
Accuray subsidiaries and ownership
Company hierarchySubsidiaries1 record
Accuray funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accuray M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accuray
What does Accuray do?
Accuray designs, manufactures, and sells advanced radiation therapy delivery systems and supporting software for cancer treatment. Its portfolio centers on the CyberKnife robotic radiosurgery platform and the Radixact helical radiation therapy system, supplemented by treatment planning software (Accuray Precision), data management (iDMS), and adaptive therapy tools. The company also generates recurring revenue through service contracts and software upgrades sold to installed-base customers.
Is Accuray a public or private company?
Accuray is a public company. It is classified as public and is currently operating.
When was Accuray founded?
Accuray was founded in 1990. It employs 1,001 to 5,000 people.
Where is Accuray based?
Accuray is headquartered in Sunnyvale, United States, in the North America region.
How does Accuray make money?
Three revenue lines are on record. Radiotherapy System Hardware Sales are the primary driver. The others are service and Maintenance Contracts and software Licenses and Upgrades.
Who are Accuray's main competitors?
Direct peers on record are Varian Medical Systems (Siemens Healthineers), Elekta and RaySearch Laboratories. Emerging players are Brainlab, ViewRay, Mevion Medical Systems, IntraOp Medical and Sensus Healthcare. Hitachi (particle therapy systems) is listed as a broad incumbent. C-RAD is listed as an others.
Does Accuray have an API?
No public API is recorded for Accuray.
What industry is Accuray in?
Accuray's product category is Radiation Therapy Equipment. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3844.